AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports

Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more

U.K. officials are nearing a drug-pricing deal with AstraZeneca and Daiichi Sankyo to assure access to a life-extending breast cancer drug.

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports

July 8 (Reuters) - Drugmakers AstraZeneca and Daiichi Sankyo are nearing an agreement with the UK's pricing regulator for their breast cancer treatment Enhertu, ​Bloomberg News reported on Wednesday, citing ‌multiple people familiar with the matter. Th...

Astra, Daiichi eye UK drug pricing deal for Enhertu (AZN:NYSE)

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) are nearing a pricing deal to offer breast cancer therapy Enhertu within England's National Health Service. Read more here.